PARP1 inhibition by Olaparib reduces the lethality of pancreatic cancer cells and increases their sensitivity to Gemcitabine
FI: 7,419
Type: Article
Collaboration
Year: 2022
Writers
Quinonero, F; Tables, C; Munoz-Gamez, JA; Jimenez-Luna, C; Perazzoli, G; Prados, J; Melguizo, C; Ortiz, R.
Magazine
Title: BIOMEDICINE & PHARMACOTHERAPY
Quartile
- D1